THURSDAY, June 12, 2025 (HealthDay News) — A newly approved shot could soon help protect babies from respiratory syncytial ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

People in Northern Ireland are being reminded that a potentially life-saving vaccination aimed at protecting newborns and ...

Here’s what causes colds to spread so easily, how long they are usually contagious and how they’re most commonly treated.

After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.

Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...

Kennedy on Wednesday named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this ...